ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Effects of Timing it Right Brain Tumor Support Program (TIRBTSP) on clinical outcome for patients diagnosed with sellar region tumors.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeThis study was aimed to investigate the impact of Timing it Right Brain Tumor Support Program (TIRBTSP) on clinical outcome for patients diagnosed with sellar region tumors.
methodsThis study adopted a prospective historical control study to compare and analyze the application effect of the TIR theory in patients with sellar region tumors treated by neuroendoscopic endonasal approach. The control group included patients admitted from April to May 2023, while the intervention group consisted of patients admitted from November to December 2023. The intervention group received TIRBTSP intervention (n = 40), and the control group received routine nursing intervention (n = 40). Assessments were conducted at baseline, before discharge, and 30 days after discharge. Discharge readiness and discharge guidance were evaluated using the Readiness for Hospital Discharge Scale (RHDS) and the Quality of Discharge Teaching Scale (QDTS), respectively.
resultsThe findings of the study demonstrated that the total score of discharge readiness, coping ability, and expected support score were all elevated in the experimental group in comparison to the control group. Significant disparities were identified between the intervention and control groups in the total score of discharge teaching quality evaluation, the actual content received, and the effectiveness of teaching techniques, exhibiting statistically higher values in the group as compared to the control group. Additionally, the readmission rate within 30 days in the intervention group was lower than that in the control group; there is no significant difference in the length of hospital stay between the two groups.
conclusionAn effective TIRBTSP intervention plays a pivotal role in enhancing the discharge readiness of patients, mitigating the occurrence of short-term complications among individuals diagnosed with sellar tumors, and facilitating their overall recovery.
Indexed as
Identifiers
40728576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.